Parker Benjamin L, Thaysen-Andersen Morten, Fazakerley Daniel J, Holliday Mira, Packer Nicolle H, James David E
From the ‡Charles Perkins Centre, School of Molecular Bioscience and.
¶Department of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, Australia.
Mol Cell Proteomics. 2016 Jan;15(1):141-53. doi: 10.1074/mcp.M115.054221. Epub 2015 Nov 4.
Insulin resistance (IR) is a complex pathophysiological state that arises from both environmental and genetic perturbations and leads to a variety of diseases, including type-2 diabetes (T2D). Obesity is associated with enhanced adipose tissue inflammation, which may play a role in disease progression. Inflammation modulates protein glycosylation in a variety of cell types, and this has been associated with biological dysregulation. Here, we have examined the effects of an inflammatory insult on protein glycosylation in adipocytes. We performed quantitative N-glycome profiling of membrane proteins derived from mouse 3T3-L1 adipocytes that had been incubated with or without the proinflammatory cytokine TNF-alpha to induce IR. We identified the regulation of specific terminal N-glycan epitopes, including an increase in terminal di-galactose- and a decrease in biantennary alpha-2,3-sialoglycans. The altered N-glycosylation of TNF-alpha-treated adipocytes correlated with the regulation of specific glycosyltransferases, including the up-regulation of B4GalT5 and Ggta1 galactosyltransferases and down-regulation of ST3Gal6 sialyltransferase. Knockdown of B4GalT5 down-regulated the terminal di-galactose N-glycans, confirming the involvement of this enzyme in the TNF-alpha-regulated N-glycome. SILAC-based quantitative glycoproteomics of enriched N-glycopeptides with and without deglycosylation were used to identify the protein and glycosylation sites modified with these regulated N-glycans. The combined proteome and glycoproteome workflow provided a relative quantification of changes in protein abundance versus N-glycosylation occupancy versus site-specific N-glycans on a proteome-wide level. This revealed the modulation of N-glycosylation on specific proteins in IR, including those previously associated with insulin-stimulated GLUT4 trafficking to the plasma membrane.
胰岛素抵抗(IR)是一种复杂的病理生理状态,由环境和基因扰动共同引起,并导致包括2型糖尿病(T2D)在内的多种疾病。肥胖与脂肪组织炎症增强有关,这可能在疾病进展中起作用。炎症在多种细胞类型中调节蛋白质糖基化,这与生物失调有关。在此,我们研究了炎症刺激对脂肪细胞中蛋白质糖基化的影响。我们对从小鼠3T3-L1脂肪细胞衍生的膜蛋白进行了定量N-糖组分析,这些脂肪细胞在有或没有促炎细胞因子TNF-α的情况下孵育以诱导IR。我们确定了特定末端N-聚糖表位的调节,包括末端二半乳糖的增加和双天线α-2,3-唾液酸聚糖的减少。TNF-α处理的脂肪细胞中N-糖基化的改变与特定糖基转移酶的调节相关,包括B4GalT5和Ggta1半乳糖基转移酶的上调以及ST3Gal6唾液酸转移酶的下调。敲低B4GalT5可下调末端二半乳糖N-聚糖,证实该酶参与TNF-α调节的N-糖组。基于SILAC的富集N-糖肽在有无去糖基化情况下的定量糖蛋白质组学用于鉴定被这些调节的N-聚糖修饰的蛋白质和糖基化位点。蛋白质组和糖蛋白质组的联合工作流程在蛋白质组水平上提供了蛋白质丰度变化与N-糖基化占有率与位点特异性N-聚糖的相对定量。这揭示了IR中特定蛋白质上N-糖基化的调节,包括那些先前与胰岛素刺激的GLUT4转运到质膜相关的蛋白质。